Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 7+ | XN575 | IM / RA |
Client called in stating she was experiencing soreness, redness, and swelling at the injection site and found it difficult to raise her arm. Client stated the symptoms began the day after receiving her Tdap booster and have not improved. Client stated she will continue to apply ice to the injection site and has found relief with over the counter pain relievers. Client shared she will continue to monitor and seek medical attention if symptoms don't improve or worsen.